Author's reply to "Face-mask non-invasive ventilation plus high-flow nasal oxygen in COVID-19 patients: "one size fits all" or tailored approach?": always tailored, with a trial!
Minerva Anestesiol
.
2022 Jul-Aug;88(7-8):644-646.
doi: 10.23736/S0375-9393.22.16669-1.
Authors
Tomas Urbina
1
,
Alexandre Elabbadi
2
3
,
Guillaume Voiriot
2
3
,
Hafid Ait-Oufella
4
2
5
Affiliations
1
Intensive Care Unit, Saint-Antoine Hospital, Assistance Publique-Hôpitaux de Paris (AP-HP), Paris, France - tomas.urbina@aphp.fr.
2
Sorbonne University, Pierre et Marie-Curie University, Paris, France.
3
Intensive Care Unit, Tenon Hospital, Assistance Publique-Hôpitaux de Paris (AP-HP), Paris, France.
4
Intensive Care Unit, Saint-Antoine Hospital, Assistance Publique-Hôpitaux de Paris (AP-HP), Paris, France.
5
Inserm U970, Cardiovascular Research Center, University of Paris, Paris, France.
PMID:
35829686
DOI:
10.23736/S0375-9393.22.16669-1
No abstract available
Publication types
Comment
MeSH terms
COVID-19* / therapy
Humans
Masks
Noninvasive Ventilation*
Oxygen
Respiration, Artificial
Substances
Oxygen